Finland· FI-REL-REL55451
Exocin
A ofloxacin product containing ofloxacin, registered in Finland by Orifarm Oy. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Ofloxacin · ATC S01AE01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Ofloxacin
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- S01AE01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 mg, AT
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOCUFLOXAllergan, Inc.
- PolandFloxalMedezin Sp. z o.o.
- NetherlandsOfloxacine Devatis 3 mg/ml, oogdruppels, oplossing, verpakking voor éénmalig gebruikDevatis GmbH
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- CzechiaFLOXALDr. Gerhard Mann, Chem.- pharm. Fabrik GmbH, Berlín
- FranceMONOOX 1,5 mg/0,5 ml, collyre en solution en récipient unidoseHORUS PHARMA
- SwedenOfloxacin mibe 3 mg/ml Ögondroppar, lösningmibe GmbH Arzneimittel
- United KingdomExocin 0.3% eye dropsMawdsley-Brooks & Company Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f3f41be-0a37-44dd-ab9f-81f51d96fc32 GET /v1/drugs/6f3f41be-0a37-44dd-ab9f-81f51d96fc32?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": null,
"ddd_unit": null,
"strength": "3 mg/ml",
"atc_label": "ofloksasiini",
"ma_number": "37473",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL55451",
"authorised_at": "2020-03-13"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.